Selected References
DiRenzo D, Barrett FS, Perin J, Darrah E, Christopher-Stine L, Griffiths RR (2024). Impact of psilocybin on peripheral cytokine production. Psychedelic Medicine, 2(2):109-115. (https://www.liebertpub.com/doi/full/10.1089/psymed.2023.0039)
Doss MK, Samaha J, Barrett FS, Griffiths RR, de Wit H, Gallo, DA, Koen JD (2023) Unique effects of sedatives, dissociatives, psychedelics, stimulants, and cannabinoids on episodic memory: A review and reanalysis of acute drug effects on recollection, familiarity, and metamemory. Psychological Review, 131(2):523-562. (https://pubmed.ncbi.nlm.nih.gov/38095937/)
Medeiros GC, Matheson M, Demo I, Reid MJ, Matheson S, Twose C, Smith GS, Gould TD, Zarate CA, Barrett FS, Goes FS (2023). Brain-based correlates of antidepressant response to ketamine: A comprehensive systematic review of neuroimaging studies. Lancet Psychiatry, 10(10): 790-800. (https://pubmed.ncbi.nlm.nih.gov/37625426/)
Sayali C, Barrett FS (2023). The costs and benefits of psychedelics on cognition and mood. Neuron, 111(5): 614-630. (https://pubmed.ncbi.nlm.nih.gov/36681076/)
Gaddis A, Lidstone DE, Nebel MB, Griffiths RR, Mostofsky SH, Mejia AF, Barrett FS (2022). Psilocybin induces spatially constrained alterations in thalamic functional organization and connectivity. NeuroImage, 260:119434. (https://pubmed.ncbi.nlm.nih.gov/35792293/)
Doss MK, Madden MB, Gaddis A, Nebel MB, Griffiths RR, Mathur BN, Barrett FS (2022). Models of psychedelic drug action: Modulation of cortical-subcortical circuits. Brain, 145(2):441-456. (https://pubmed.ncbi.nlm.nih.gov/34897383/)